{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:49:15Z","timestamp":1762195755081,"version":"build-2065373602"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    HMGA1, an architectural transcription factor that plays a crucial role in tumorigenesis, chemotherapy resistance and cancer stem cell transformation in many human cancers, is intrinsically disordered and cannot be targeted by conventional small molecule drug therapy. While HMGA1 is required and essential for normal growth and development, HMGA1 expression occurs at very low levels in normal healthy adult cells. In contrast, HMGA1 is expressed at very high levels in many different types of human cancer cells. Since HMGA1 cannot be targeted using conventional small molecule drug therapy, alternative approaches are needed to target HMGA1 in new cancer therapies. Here, we explored the use of serotype 5 adenoviruses (Ad5) engineered 1) to sequester overexpressed HMGA1 in cancer cells using an HMGA1 hyper binding site (HBS) inserted into the Ad5 genome and 2) to suppress HMGA1 synthesis in cancer cells by incorporating exogenous genes into the Ad5 genome that encode an artificial HMGA1 cis-antisense transcript (AAT) and that encode a gene to express an HMGA1-targeted shRNA transcript (shRNA). The three engineered Ad5s were tested in MiaPaCa-2, PANC-1 and BxPC-3 human pancreatic cancer cell lines and in the ZR-75 human breast cancer cell line. Cancer cell viabilities and cell migration capability decreased by ~50\u201375% with HBS viruses and by 25\u201350% for shRNA and AAT viruses. Anchorage-independent migration capacity decreased by 60\u201370% with all three HBS, shRNA and AAT viruses. HMGA1 mRNA transcripts levels varied from 100 to 300 copies per cell in untreated cells and these levels were not significantly affected by treatment with the HBS and shRNA viruses, however the HMGA1 mRNA levels increased by ~3-fold upon AAT virus treatment. HMGA1 protein levels decreased in the range of 40, 50 and 70% with shRNA, AAT and HBS viruses, respectively. The HBS virus designed to sequester HMGA1 proved most effective overall in suppressing HMGA1 oncogenic activity in these\n                    <jats:italic>\n                      <jats:italic>in vitro<\/jats:italic>\n                    <\/jats:italic>\n                    cell-based studies compared to the AAT and shRNA viruses.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0335934","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:27:52Z","timestamp":1762194472000},"page":"e0335934","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sequestration and suppressed synthesis of oncogenic HMGA1 using engineered adenoviruses decreases human pancreatic and breast cancer cell characteristics"],"prefix":"10.1371","volume":"20","author":[{"given":"Md. Sharif","family":"Hasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuisong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatema B.","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan F.","family":"Blossey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eian","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret B.","family":"Bogomolny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trang","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6462-665X","authenticated-orcid":true,"given":"Michael A.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"pone.0335934.ref001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1874091X01307010073","article-title":"Characterization of the Stoichiometry of HMGA1\/DNA Complexes","volume":"7","author":"M Watanabe","year":"2013","journal-title":"Open Biochem J"},{"issue":"11","key":"pone.0335934.ref002","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.3390\/ijms20112733","article-title":"The High Mobility Group A1 (HMGA1) Chromatin Architectural Factor Modulates Nuclear Stiffness in Breast Cancer Cells","volume":"20","author":"B Senigagliesi","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0335934.ref003","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/ijms21010362","article-title":"HMGA Proteins in Stemness and Differentiation of Embryonic and Adult Stem Cells","volume":"21","author":"S Parisi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"pone.0335934.ref004","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/bjc.2017.216","article-title":"HMGA1 expression levels are elevated in pancreatic intraepithelial neoplasia cells in the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer","volume":"117","author":"MJ Veite-Schmahl","year":"2017","journal-title":"Br J Cancer"},{"issue":"8","key":"pone.0335934.ref005","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1158\/0008-5472.CAN-17-3045","article-title":"Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression","volume":"78","author":"L Resar","year":"2018","journal-title":"Cancer Res"},{"issue":"6","key":"pone.0335934.ref006","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151601","article-title":"HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation","volume":"133","author":"L Chia","year":"2023","journal-title":"J Clin Invest"},{"issue":"4","key":"pone.0335934.ref007","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4251\/wjgo.v16.i4.1256","article-title":"Computed tomography-based radiomics diagnostic approach for differential diagnosis between early- and late-stage pancreatic ductal adenocarcinoma","volume":"16","author":"S Ren","year":"2024","journal-title":"World J Gastrointest Oncol"},{"key":"pone.0335934.ref008","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.2147\/IJN.S335588","article-title":"Emodin-Conjugated PEGylation of Fe3O4 Nanoparticles for FI\/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer","volume":"16","author":"S Ren","year":"2021","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"pone.0335934.ref009","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2011.10.005","article-title":"HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines","volume":"315","author":"M Watanabe","year":"2012","journal-title":"Cancer Lett"},{"key":"pone.0335934.ref010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.omto.2018.01.002","article-title":"Adenovirus-Mediated Delivery of Decoy Hyper Binding Sites Targeting Oncogenic HMGA1 Reduces Pancreatic and Liver Cancer Cell Viability","volume":"8","author":"F Hassan","year":"2018","journal-title":"Mol Ther Oncolytics"},{"issue":"2","key":"pone.0335934.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192882","article-title":"A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy","volume":"13","author":"F Hassan","year":"2018","journal-title":"PLoS One"},{"key":"pone.0335934.ref012","article-title":"Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells","author":"E Madan","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"4","key":"pone.0335934.ref013","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"SA Bustin","year":"2009","journal-title":"Clin Chem"},{"issue":"1","key":"pone.0335934.ref014","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2013.10.008","article-title":"Osteopontin-a alters glucose homeostasis in anchorage-independent breast cancer cells","volume":"344","author":"Z Shi","year":"2014","journal-title":"Cancer Lett"},{"issue":"8","key":"pone.0335934.ref015","article-title":"Energy metabolism during anchorage-independence. Induction by osteopontin-c","volume":"9","author":"Z Shi","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"pone.0335934.ref016","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1158\/0008-5472.CAN-05-2637","article-title":"HMGA1 inhibits the function of p53 family members in thyroid cancer cells","volume":"66","author":"F Frasca","year":"2006","journal-title":"Cancer Res"},{"issue":"8","key":"pone.0335934.ref017","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.126","article-title":"High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria","volume":"3","author":"F Esposito","year":"2012","journal-title":"Cell Death Dis"},{"issue":"9","key":"pone.0335934.ref018","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/sj.cdd.4401839","article-title":"High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity","volume":"13","author":"GM Pierantoni","year":"2006","journal-title":"Cell Death Differ"},{"issue":"4","key":"pone.0335934.ref019","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1566524016666160316152147","article-title":"The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development","volume":"16","author":"TF Sumter","year":"2016","journal-title":"Curr Mol Med"},{"issue":"21","key":"pone.0335934.ref020","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1038\/sj.onc.1208501","article-title":"Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone\/prolactin cell pituitary adenomas and natural killer cell lymphomas","volume":"24","author":"M Fedele","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"pone.0335934.ref021","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tips.2011.09.004","article-title":"Interleukin-15 biology and its therapeutic implications in cancer","volume":"33","author":"JC Steel","year":"2012","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"pone.0335934.ref022","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrm2738","article-title":"Regulatory roles of natural antisense transcripts","volume":"10","author":"MA Faghihi","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"pone.0335934.ref023","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13046-020-01700-0","article-title":"Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark","volume":"39","author":"S Zhao","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"pone.0335934.ref024","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6750-7-21","article-title":"Potential pitfalls in the accuracy of analysis of natural sense-antisense RNA pairs by reverse transcription-PCR","volume":"7","author":"F Haddad","year":"2007","journal-title":"BMC Biotechnol"},{"issue":"11","key":"pone.0335934.ref025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026908","article-title":"A simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time","volume":"6","author":"SM Smith","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"pone.0335934.ref026","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/sim.2271","article-title":"Quantile regression methods for reference growth charts","volume":"25","author":"Y Wei","year":"2006","journal-title":"Stat Med"},{"key":"pone.0335934.ref027","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.108281","article-title":"The Natural Antisense Transcript-Targeted Regulation Technology Using Sense Oligonucleotides and Its Application","author":"M Nishizawa","year":"2023","journal-title":"Oligonucleotides - Overview and Applications. IntechOpen"},{"issue":"8","key":"pone.0335934.ref028","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00018-012-1216-x","article-title":"Stabilization of human interferon-\u03b11 mRNA by its antisense RNA","volume":"70","author":"T Kimura","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"06","key":"pone.0335934.ref029","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4236\/jct.2023.146021","article-title":"Blocking Translation of Oncogenic mRNA","volume":"14","author":"KN Christie","year":"2023","journal-title":"JCT"},{"journal-title":"N\/A","article-title":"Block or degrade? Balancing on- and off-target effects of antisense strategies against transcripts with expanded triplet repeats in DM1.","author":"N El Boujnouni","key":"pone.0335934.ref030"},{"key":"pone.0335934.ref031","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-1119(01)00689-8","article-title":"Molecular biology of HMGA proteins: hubs of nuclear function","volume":"277","author":"R Reeves","year":"2001","journal-title":"Gene"},{"key":"pone.0335934.ref032","doi-asserted-by":"crossref","first-page":"756988","DOI":"10.3389\/fmed.2021.756988","article-title":"Exogenous HMGB1 Promotes the Proliferation and Metastasis of Pancreatic Cancer Cells","volume":"8","author":"L Zhu","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"pone.0335934.ref033","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1089\/104303401750270977","article-title":"Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect","volume":"12","author":"D Harrison","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"6","key":"pone.0335934.ref034","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/sj.cgt.7700077","article-title":"Adenovirus lacking the 19-kDa and 55-kDa E1B genes exerts a marked cytotoxic effect in human malignant cells","volume":"6","author":"PM Duque","year":"1999","journal-title":"Cancer Gene Ther"},{"issue":"5286","key":"pone.0335934.ref035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumor cells","volume":"274","author":"JR Bischoff","year":"1996","journal-title":"Science"},{"issue":"6","key":"pone.0335934.ref036","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jacc.2013.10.062","article-title":"Coxsackie and adenovirus receptor is a modifier of cardiac conduction and arrhythmia vulnerability in the setting of myocardial ischemia","volume":"63","author":"RFJ Marsman","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"pone.0335934.ref037","doi-asserted-by":"crossref","first-page":"883","DOI":"10.15252\/msb.20167144","article-title":"Gene-specific correlation of RNA and protein levels in human cells and tissues","volume":"12","author":"F Edfors","year":"2016","journal-title":"Mol Syst Biol"},{"issue":"11","key":"pone.0335934.ref038","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3390\/genes14112065","article-title":"Workability of mRNA Sequencing for Predicting Protein Abundance","volume":"14","author":"EA Ponomarenko","year":"2023","journal-title":"Genes (Basel)"},{"issue":"1","key":"pone.0335934.ref039","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1038\/s41598-023-32256-6","article-title":"Parallel recovery of chromatin accessibility and gene expression dynamics from frozen human regulatory T cells","volume":"13","author":"YY Wong","year":"2023","journal-title":"Sci Rep"},{"key":"pone.0335934.ref040","article-title":"Adenoviral vector-based vaccines and gene therapies: Current status and future prospects.","volume-title":"Adenoviruses","author":"B Agrawal","year":"2018"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:27:59Z","timestamp":1762194479000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335934"}},"subtitle":[],"editor":[{"given":"Antonio","family":"Palumbo jr","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0335934","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2025,11,3]]}}}